We appreciate the constructive remarks by Chung-Wei Christine Lin and colleagues regarding our systematic review and resulting recommendations.1 Our systematic review and meta-analysis were explicitly ...

Celcuity Inc (CELC) reports significant clinical progress and strategic funding, despite increased losses and rising expenses.

Several big investors, including State Street, Bridgewater Associates, and T. Rowe Price, have sold part of their NVDA stakes ...

2025 Financial Outlook Heartflow expects total revenue for the full year 2025 to be in the range of $173.0 million to $173.5 million, representing year-over-year growth of approximately 37.5% to 38.0% ...